Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. RECARBRIO
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

RECARBRIO

Medicine - Posted on Apr 08 2021
Active substance (DCI)
  • imipénème
  • cilastatine
  • relebactam
history (2)
  • 3/24/21

    RECARBRIO (imipénème/ cilastatine/ relebactam)

    Modifications de l’AMM. Avis favorable au maintien du remboursement dans les indications de l’AMM uniquement en dernier reco...
    icône flèche
  • 9/23/20

    RECARBRIO

    Key points Positive opinion for reimbursement in the market authorisation (MA) indications, only as a last resort for patien...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • J01DH56
Manufacturer
MSD FRANCE
Presentation

RECARBRIO 500 mg/500 mg/250 mg, poudre pour solution pour perfusion
25 flacons en verre de 20 ml (CIP : 34009 302 012 6 8)

All our publications
    Bacterial infections Drug therapy

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
Pe1GS13WWB3u7N1K